This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE
What will it take to shatter systemic barriers obstructing timely and equitable pediatric care?
According to our next guest, Dr. Sharief Taraman, Chief Executive Officer of Cognoa, it starts with responsible AI adoption designed to uplift all patients.
As creators of the first and only FDA-authorized diagnostic for autism, Cognoa continues pioneering digital health solutions upholding diversity, cost savings, and care team empowerment.
While together, Dr. Taraman passionately shares Cognoa's mission of democratizing quality care, how their autism diagnostic is dissolving geographic and financial obstacles through telehealth accessibility, and why he urges investors to back ventures tackling pediatric device gaps spanning ADHD, anxiety, speech impediments, and more.
Join us as Dr. Taraman shares why he and his team at Cognoa are so dedicated to unlocking equitable pediatric care. Lets go!
How Cognoa launched 1st ever FDA-authorized diagnostic test for autism
Extracting digital biomarkers from parental questionnaires and child observation videos
Reducing disparities by maintaining high accuracy across patient demographics
Auto-generating necessary evaluation documentation to alleviate administrative burdens
Cognoa’s pursuit to earn breakthrough designation for condensed 6-week autism behavioral therapy
About our Guest:
Dr. Sharief Taraman, MD, DABPN, DABPM, FAAP, is dual board-certified in Neurology with special qualifications in Child Neurology from the American Board of Psychiatry and Neurology and Clinical Informatics from the American Board of Preventive Medicine. He formerly served as the Division Chief of Pediatric Neurology for the CHOC Children’s Specialists Pediatric Subspecialty Faculty and is a Clinical Associate Professor of Pediatrics at UC Irvine School of Medicine. Dr. Taraman is the Chief Executive Officer of Cognoa, a leading early childhood development and pediatric behavioral health company, creator of the first and only FDA
authorized diagnostic for autism and early, rapid developmental health evaluation, designed to increase childhood access to life-changing early intervention and treatment of behavioral health conditions.